Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lumpipulse G CA19-9-N

K-Number: K191973 · 2019-10-22

Decision Date2019-10-22
Product CodeNIG
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Lumpipulse G CA19-9-N is the device name listed in this FDA 510(k) record. The listed applicant is Fujirebio Dianostics, Inc.. It received FDA 510(k) clearance on 2019-10-22 under 510(k) number K191973. The device is classified under product code NIG. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lumpipulse G CA19-9-N?

Lumpipulse G CA19-9-N is a medical device that received FDA 510(k) clearance on 2019-10-22. The listed applicant is Fujirebio Dianostics, Inc.. The 510(k) number is K191973.

When did Lumpipulse G CA19-9-N receive FDA 510(k) clearance?

Lumpipulse G CA19-9-N received FDA 510(k) clearance on 2019-10-22, under 510(k) number K191973.

Who is the listed applicant for Lumpipulse G CA19-9-N?

The FDA 510(k) record lists Fujirebio Dianostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lumpipulse G CA19-9-N?

The FDA product code for Lumpipulse G CA19-9-N is NIG.

Related Devices (Code: NIG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.